BioPhorum Drug Substance has published an Industry Statement on Annex 1, 8.134: Verification of Sterility Assurance, bringing much needed clarity on how sterility assurance for single-use systems (SUS) should be verified
Some bioregulator peptides were developed at St
Ethics declarations Competing interests D.H.R has received personal remuneration from services as a scientific advisor to Abbvie, Altimmune, Amgen, AstraZeneca, Boehringer Ingelheim, Biohaven, Calibrate, Carmot/Roche, CINRx, Currax, Epitomee, Fractyl, Gila, Lilly, Nestle, Novo Nordisk, Pfizer, Regeneron, Scientific Intake, Source Bio, Structure Therapeutics, Wondr Health, and Zealand, She serves on Speakers Bureau for Novo Nordisk and Lilly
P.ChapmanM